Overview

Multimodal Analgesia Methods in Patients Undergoing IPACK Block in Knee Arthroplasty

Status:
Recruiting
Trial end date:
2020-03-15
Target enrollment:
0
Participant gender:
All
Summary
A comparison of two pain control methods - the combination of Adductor Canal Block (ACB)/Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (IPACK) versus the Periarticular Injection (PAI)/ Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (IPACK) - in patients undergoing total knee arthroplasty. dexketoprofen and paracetamol will be added to both groups and multimodal analgesia will be applied. Primary outcome is NRS pain scores with ambulation on postoperative day one (24 hours post-block administration).
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Ankara Diskapi Training and Research Hospital
Treatments:
Bupivacaine
Dexketoprofen trometamol
Criteria
Inclusion Criteria:

- Patients with osteoarthritis scheduled for a primary either partial or total knee
arthroplasty with a participating surgeon

- Age 18 to 80 years

- Planned use of regional anesthesia

- Ability to follow study protocol

- Patients of participating surgeons

Exclusion Criteria:

- Hepatic or renal insufficiency

- Younger than 18 years old and older than 80

- Patients undergoing general anesthesia

- Allergy or intolerance to one of the study medications

- BMI > 40

- Diabetes

- ASA of IV

- Chronic gabapentin/pregabalin use (regular use for longer than 3 months)

- Chronic opioid use (taking opioids for longer than 3 months, or daily oral morphine
equivalent of >5mg/day for one month)